首页> 美国卫生研究院文献>Tropical Medicine and Health >Clinical Manifestations and Management of Dengue/DHF/DSS
【2h】

Clinical Manifestations and Management of Dengue/DHF/DSS

机译:登革热/ DHF / DSS的临床表现和管理

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Dengue is one of the most important mosquito-borne viral illnesses. The first DHF outbreak was reported from the Philippines in 1953. Initially it was endemic only in Southeast Asia and the Western Pacific regions. After about 50 years from the first outbreak, it spread globally to almost every continent including North and South America, Australia and Africa. The majority of cases during the 50s to 80s were children, but today the disease affects both children and adults of all age groups. The disease is caused by dengue viruses that have four serotypes: dengue 1, dengue 2, dengue 3 and dengue 4. Primary infection usually results in milder illness, while more severe disease occurs in cases of repeated infection with different serotypes. In this paper clinical manifestations and management of dengue/DHF/DSS are summarized.
机译:登革热是最重要的蚊媒病毒性疾病之一。 1953年,菲律宾报告了首例DHF疫情。最初仅在东南亚和西太平洋地区流行。首次爆发后约有50年,它在全球蔓延到几乎每个大陆,包括北美和南美,澳大利亚和非洲。在50到80年代,大多数病例是儿童,但是今天,这种疾病影响到各个年龄段的儿童和成年人。该疾病是由具有四种血清型的登革热病毒引起的:登革热1,登革热2,登革热3和登革热4。原发感染通常会导致较轻的疾病,而反复感染不同血清型的情况则更严重。本文总结了登革热/ DHF / DSS的临床表现和管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号